Orthofix Medical (OFIX) Income from Continuing Operations (2010 - 2026)

Orthofix Medical (OFIX) has reported Income from Continuing Operations for 17 consecutive years, with -$15.8 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Income from Continuing Operations fell 12.19% year-over-year to -$15.8 million; the trailing twelve-month figure through Jun 2026 stood at -$43.7 million (up 54.24% YoY), and the FY2025 full-year result was -$74.2 million, up 24.18% from the prior year.
• Income from Continuing Operations was -$15.8 million for Q2 2026 at Orthofix Medical, up from -$20.9 million in the prior quarter.
• The five-year high for Income from Continuing Operations was $15.8 million in Q4 2025, with the low at -$60.9 million in Q1 2023.
• Historically, Income from Continuing Operations has averaged -$19.5 million across 5 years, with a median of -$18.4 million in 2026.
• Annual changes were most pronounced in 2023 — Income from Continuing Operations plunged 1684.01% — and 2025, when it jumped 1659.55%.
• Tracing OFIX's Income from Continuing Operations over 5 years: stood at -$5.9 million in 2022, then surged by 195.54% to $5.6 million in 2023, then sank by 117.9% to -$1.0 million in 2024, then jumped by 1659.55% to $15.8 million in 2025, then slumped by 200.2% to -$15.8 million in 2026.
• Per Business Quant data, the three most recent Income from Continuing Operations figures were -$15.8 million in Q2 2026, -$20.9 million in Q1 2026, and $15.8 million in Q4 2025.